Skip to main content
. 2019 Oct 4;23(10):1011–1020. doi: 10.1007/s12603-019-1269-8

Table 2.

Intervention related measures

Total (n=81) Responders BBS ≥5 increase (n=29) Non-responders BBS <5 increase (n=52) OR, 95% CI P value
Target variables; median (IQR)
Attendance, n 34.0 (30.0–37.0) 34.0 (29.0–37.0) 35.0 (30.3–38.0) 0.98 (0.94–1.03) 0.418
High Intensity strength, n 16.0 (3.5–27.0) 15.0 (3.0–23.5) 21.0 (6.5–27.8) 0.97 (0.93–1.01) 0.167
High Intensity balance, n 24.0 (11.0–31.5) 21.0 (9.0–28) 24.0 (14.3–33.0) 0.97 (0.93–1.01) 0.116
Adverse event, n 2.0 (0.5–6.0) 3.0 (0–9.5) 2.0 (1.0–5.0) 1.02 (0.96–1.10) 0.498
High Motivation, n 20.0 (8.0–30.0) 10.0 (4.5–28.5) 23.0 (9.5–31.0) 0.97 (0.94–1.01) 0.158
Other applicability variables; median (IQR)
HI strength + balance, n 13.0 (3.0–25.0) 9 (3.0–22.8) 19.0 (5.0–26.0) 0.97 (0.93–1.02) 0.217
HI+MI strength, n 32 (23.0–36.0) 30.0 (20.0–34.0) 33.0 (24.3–36.8) 0.97 (0.93–1.01) 0.172
HI+MI balance, n 33 (27.5–37.0) 31 (26.0–35.5) 33.5 (28.3–37.0) 0.98 (0.94–1.02) 0.319
Effective workout time/session minutes 17.6 (15.1–19.6) 16.6 (14.1–19.3) 17.9 (15.3–19.7) 1.00 (1.00–1.00) 0.362
Peripheral strain*, n 13.0 (5.5–23.5) 8.5 (2.5–22.5) 19 (8.5–25.0) 0.96 (0.91–1.01) 0.075
New medical conditions †, n (%)
Falls 36 (44.4) 13 (44.8) 23 (44.2) 1.02 (0.41–2.56) 0.959
Hospital stay 10 (12.3) 5 (17.2) 5 (9.6) 1.52 (0.62–3.73) 0.357
Medical event and illness without hospitalization 37 (45.7) 11 (37.9) 26 (50.0) 0.61 (0.24–1.54) 0.297

Values are expressed as median (IQR) or n (%); *Number of sessions where muscle fatigue in the lower-limb were the reason for stopping, in sessions with high intensity in strength exercises; † during the intervention; Abbreviations: BBS, Berg Balance Scale; BBS ≥5 increase, difference between follow up and baseline ≥5; BBS <5 increase, difference between follow up and baseline <5; HI, High Intensity; HI+MI, High Intensity + Moderate Intensity.